Inventor profile of:

Dolores Schendel

City:

Munich

Country:

Germany

Published Applications:

14

Last publication date:

2024-03-14

Recent patent applications by Schendel Dolores

Dolores Schendel from Munich, DE has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2024-03-14
US20240083967A1
Chemistry; metallurgy

T CELL RECEPTORS AND USES THEREOF

#2 | 2021-08-26
US20210261947A1
Chemistry; metallurgy

Method of detecting new immunogenic T cell epitopes and isolating new antigen-specific T cell receptors by means of an MHC cell library

#3 | 2019-06-06
US20190169261A1
Chemistry; metallurgy

T cell receptors and uses thereof

#4 | 2019-01-03
US20190002515A1
Chemistry; metallurgy

Generation of antigen-specific TCRs

#5 | 2019-01-03
US20190000949A1
Human necessities

Dendritic cell composition

#6 | 2018-08-30
US20180245242A1
Chemistry; metallurgy

T cell receptor library

#7 | 2018-08-23
US20180237520A1
Chemistry; metallurgy

Method for generating antibodies against T cell receptor

#8 | 2018-03-15
US20180073013A1
Chemistry; metallurgy

Method of detecting new immunogenic T cell epitopes and isolating new antigen-specific T cell receptors by means of an MHC cell library

#9 | 2016-09-01
US20160250308A1
Human necessities

Semi-allogenic anti-tumour vaccine with HLA haplo-identical antigen-presenting cells

#10 | 2011-07-28
US20110182945A1
Human necessities

Semi-allogenic anti-tumour vaccine with HLA haplo-identical antigen-presenting cells

#11 | 2010-08-12
US20100203086A1
Human necessities

Attack of tumor cells with missing, low or aberrant MHC expression by combining non MHC-restricted T-cells/NK-cells and MHC-restricted cells

#12 | 2010-07-29
US20100189728A1
Chemistry; metallurgy

Generation of antigen specific T cells

#13 | 2010-06-08
US10190281
-

Attack of tumor cells with missing, low or aberrant MHC expression by combining non MHC-restricted T-cells/NK-cells and MHC-restricted cells

#14 | 2005-08-11
US20050175596A1
Human necessities

Semi-allogenic anti-tumour vaccine with HLA haplo-identical antigen-presenting cells

InventorID:

1635489 ⎘